Phospholipase A2 (PLA2) catalyzes the hydrolysis of the fatty acid ester in the 2-position of 3-sn-phospholipads. This reaction produces lysophospholipids and free fatty acids in equimolar amounts. The products of the hydrolysis are proinflammatory factors. For example, lysophosphatidylcholine stimulates the adhesion of leukocytes and the expression of growth factors in endothelial cells. Three major types of PLA2 have been identified in mammalian tissues: nonpancreatic secretory PLA2 (type II), pancreatic secretory PLA2 (type I), and cytosolic PLA2. Human type II PLA2 is synthesized and secreted by a variety of cells such as platelets, neutrophils, and mast cells, and found in fluids at various sites of inflammations, such as synovial fluids in patients with rheumatoid arthritis. Also, transcription of the gene for this extracellular enzyme is induced by inflammatory cytokines including tumor necrosis factor and interleukins. Thus, PLA2 has been implicated in the pathologenesis of various inflammatory diseases.
Chondoroitin sulfate proteoglycans (CSPGs) of the arterial intima appear to be responsible for the formation of complexes with low density lipoproteins (LDLs) that contain apoB-100. This may be a step in the normal exchange of components between the circulating plasma and the arterial wall. However, during atherogenesis, this process seems to contribute to continuous focal deposition of choresterol-rich LDL in lesions. In fact, increased affinity of CSPG secreted by proliferating smooth muscle cells was reported, and it was suggested that the high affinity-CSPG could contribute to the LDL deposition [Camejo, G. et al., (1993) J. Biol. Chem., 268,14131-14137] . The authors of this paper introduced here showed that human type II PLA2 interacts with proteoglycans via their glycosaminoglycan (GAG) moiety and that the enzyme activity may be modulated by the association of the enzyme to the GAG chains [Sartipy, P. et al., (1996) J. Biol. Chem., 271, 26307-26314] .
Under physiological ionic conditions used in the in vitro binding experiments, the type II PLA2 and LDL associate with both HS and CS. Heparin/heparan sulfate (HS) appears to be more potent in binding to both the enzyme and LDL than CS. However, the effect of the GAGS on PLA2 activity appears to be complex. With heparin/HS the effect is biphasic and eventually heparin/HS inhibits the enzyme activity at high concentrations, while CS stimulates the enzyme activity at all concentrations tested. It was suggested that the co-localization of the enzyme and LDL to CS-chains could facilitate the interaction between the enzyme and the substrate (LDL), and that the increased activity of PLA2 co-localized in extracellular CSPGs with accumulating LDL could contribute to the atherogenicity of LDL retention.
CS differs from heparin/HS regarding the structural backbone and positioning of sulfate groups. CS is composed of repeating disaccharide units of GlcA-GalNAC, and mainly bears sulfate groups at the 4-position or 6-position of the GalNAc residues. Chondroitin 4-sulfate ( C4-S) and chondroitin 6-sulfate (C6-S) that predominantly contain GlcAGalNAc(4-O-S) and GlcA-GalNAc(6-O-S) disaccharide units, respectively. CS generally contains both GlcA-GalNAC(4-O-S) and G1cA-GalNAC(6-O-S) units, the ratio of 4-O-sulfate/6-0-sulfate varies the development of animals, or malignant changes etc. The presence of two sulfate groups per one disaccharide unit was also reported.
In addition, GlcA(2-O-S)-GalNAC(6-O-5) units were contained in CS from a cultured mast cell. Although the authors did not show any sugar sequences and structural features including molecular size and patterns of sulfation in CS, the 6-O-sulfate groups in GalNAc residues of CS seem to be important for its interaction with the enzyme since C6-S at least has the ability to stimulate the enzyme activity.
The discovery that PLA2 can exhibit differential activities toward potential substrates, such as LDL, depending on the type of GAG to which the enzyme is associated, added new knowledge on relationships between GAG structure and function. The aspect of functional specificity in the polysaccharide-protein interactions is being increasingly recognized as introduced in this topic. It is an exciting time to study GAGs including CSs. After many gears spent unraveling their basic structures and general principles of biosynthesis, we are now beginning to see some specific functions of GAGs as important players in biological processes rather than structural spectators of the events happening around them.
